Home / Indicator library / Biotechnology and Medical Care / Wellell (4106) overview
Wellell (4106) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Wellell, on one pageWellell (4106) snapshot, key figures
Wellell (4106): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4106: common questions
What is 4106's P/E ratio?
4106 traded at a price-to-earnings ratio of 16.36x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 4106's price-to-book ratio?
4106's price-to-book ratio was 0.95x on 2026-08-03, taken as-is from the official public source.
What is 4106's dividend yield?
4106's cash dividend yield was 4.27% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 4106's revenue growing?
4106 reported 26.8% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4106's price / earnings high or low right now?
4106's price / earnings is 16.36x, which is below its one-year median of 17.27x and sits at the 26th percentile of the 15.77–23.20x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 4106's price / book high or low right now?
4106's price / book is 0.95x, which is above its one-year median of 0.94x and sits at the 75th percentile of the 0.88–1.03x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.